Search
Search Results
-
Novel CDK Inhibitors in Breast Cancer
Breast cancer is thought to be the most frequent kind of cancer in women globally. It is crucial to comprehend the biology of this tumor before...
-
Molecular Profiling and Personalized Medicine in Drug-Resistant Breast Cancer
The utilization of molecular profiling techniques and personalized medicine approaches in the management of breast cancer is driven by molecular...
-
Introduction to Breast Cancer and Drug Resistance
Breast cancer is the most prevalent cancer in women, worldwide. Thus, it has attained the number one spot as the most diagnosed cancer in most...
-
Emerging Therapeutic Approaches in Drug-Resistant Breast Cancer
Breast cancer, a heterogeneous and complex disease, remains a significant healthcare challenge around the world, with drug resistance being a major...
-
Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment
Despite tremendous progress in deciphering breast cancer at the genomic level, the pronounced intra- and intertumoral heterogeneity remains a major...
-
Innovative Drug Delivery Systems for Drug-Resistant Breast Cancer
Breast cancer is the most common and one of the deadliest cancers affecting women worldwide. The mainstay treatment for breast cancer is surgery and...
-
Breast Cancer: Epidemiology, Types, Diagnosis, and Treatment
Breast cancer is a complex disease, and many aspects of this disease are under intensive research. Better treatment of breast cancer can only be...
-
Current Treatment Approaches to Breast Cancer
Breast cancer is a familiar malignancy and the major reason for cancer mortality among females worldwide. Research on breast carcinoma has led to...
-
Diagnostic-Prognostic Biomarkers and Their Clinical Implication in Breast Cancer
Breast cancer (BC) is a complex disease that continues to affect global cancer fatalities with its high incidence rate. Hence, BC requires...
-
Resistance to Chemotherapy in Breast Cancer
Breast cancer (BC) is the most frequently diagnosed cancer in women and the leading cause of death for women worldwide. Conventional clinical...
-
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer
BackgroundInvasive Lobular Carcinoma (ILC) is a morphologically distinct breast cancer subtype that represents up to 15% of all breast cancers....
-
Advancing E-health Interventions in Cancer Control and Survivorship for Hispanic/Latina Breast Cancer Patients
Hispanic/Latina breast cancer survivors (BCS) in the United States experience disparities in survivorship outcomes, including worse health-related...
-
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Triple negative breast cancer (TNBC) is a heterogeneous group of tumors which lack estrogen receptor, progesterone receptor, and HER2 expression....
-
Lipid Nanocarriers for Breast Cancer Treatment
Excluding non-melanoma skin cancer, breast cancer is considered the most prevalent type of cancer among women. In addition to surgery, radiation...
-
Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort
Background27-hydroxycholesterol (HC) and 25-HC were identified as endogenous selective estrogen receptor modulators (SERMs) and estrogen receptor...
-
Diabetes and Cancer Co-management Education: Leveraging the Patient Activated Learning System (PALS) for Patients with Breast Cancer
More than 70% of cancer patients have one or more comorbid conditions, and diabetes is one of the most common and burdensome comorbidities. However,...
-
Cell Cycle Dysregulation in Breast Cancer
Cancer, a condition characterized by abnormal cell growth, is closely linked to the cell cycle. In reaction to mitogenic cues, all malignancies...
-
Hereditary Lobular Breast Cancer: A Newly Defined Syndrome
Germline CDH1 mutations were first identified in 1998 in families with a strong history of early-onset gastric cancer. Now, 25 years on, it appears...
-
How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
BackgroundIn breast cancer patients body image (BI) is a crucial aspect of quality of life (QoL). This study examined the postoperative impact of...
-
PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
Breast cancer multigene signatures (BCMS) have changed how patients with early-stage breast cancer (eBC) are managed, as they provide prognostic...
